Literature DB >> 16397861

Choosing the analysis population in non-inferiority studies: per protocol or intent-to-treat.

M Matilde Sanchez1, Xun Chen.   

Abstract

For superiority trials, the intent-to-treat population (ITT) is considered the primary analysis population because it tends to avoid the over-optimistic estimates of efficacy that results from a per-protocol (PP) population. However, the roles of the ITT population and PP population in non-inferiority studies are not clearly defined as in superiority trials. In this paper, a simulation study is conducted to systematically investigate the impact of different types of missingness and protocol violations on the conservatism or anticonservatism of analyses based on the ITT and the PP population in non-inferiority trials. We find that conservatism or anticonservatism of the PP or ITT analysis depends on many factors, including the type of protocol deviation and missingness, the treatment trajectory (for longitudinal study) and the method of handling missing data in ITT population. The requirement that non-inferiority be shown for both PP and ITT populations does not necessarily guarantee the validity of a non-inferiority conclusion and a sufficiently powered PP analysis is not necessarily powered for ITT analysis. It is important to assess the potential types and rates of protocol deviation and missingness that might occur in a non-inferiority trial and to obtain some prior knowledge regarding the treatment trajectory of the test treatment versus the active control at the design stage so that a proper analysis plan and appropriate power estimation can be carried out. In general, for the types of protocol violations and missingness considered, we find that hybrid ITT/PP analysis, which excludes non-compliant patients as in the PP analysis and properly addresses the impact of non-trivial missing data as in the MLE-based ITT analysis, is more promising by way of providing reliable non-inferiority tests. Copyright 2006 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Year:  2006        PMID: 16397861     DOI: 10.1002/sim.2244

Source DB:  PubMed          Journal:  Stat Med        ISSN: 0277-6715            Impact factor:   2.373


  35 in total

1.  Myofascial Pain Syndrome in the Elderly and Self-Exercise: A Single-Blind, Randomized, Controlled Trial.

Authors:  Minhee Kim; Minyoung Lee; Yushin Kim; Sejun Oh; Dongshin Lee; BumChul Yoon
Journal:  J Altern Complement Med       Date:  2016-02-24       Impact factor: 2.579

Review 2.  Rationale for and methods of superiority, noninferiority, or equivalence designs in orthopaedic, controlled trials.

Authors:  Patrick Vavken
Journal:  Clin Orthop Relat Res       Date:  2011-01-19       Impact factor: 4.176

3.  To treat or not to treat, that really is not the question.

Authors:  Guoqiao Wang; Gary R Cutter
Journal:  Neurol Clin Pract       Date:  2015-06

4.  Protocol adherence rates in superiority and noninferiority randomized clinical trials published in high impact medical journals.

Authors:  Nicolas A Bamat; Osayame A Ekhaguere; Lingqiao Zhang; Dustin D Flannery; Sara C Handley; Heidi M Herrick; Susan S Ellenberg
Journal:  Clin Trials       Date:  2020-07-15       Impact factor: 2.486

5.  Addressing missing data in clinical studies of kidney diseases.

Authors:  Maria E Montez-Rath; Wolfgang C Winkelmayer; Manisha Desai
Journal:  Clin J Am Soc Nephrol       Date:  2014-02-07       Impact factor: 8.237

Review 6.  Improving psychotherapy research: The example of mindfulness based interventions.

Authors:  Alberto Chiesa
Journal:  World J Methodol       Date:  2011-09-26

7.  Challenges in the design and analysis of non-inferiority trials: a case study.

Authors:  Valerie Durkalski; Robert Silbergleit; Daniel Lowenstein
Journal:  Clin Trials       Date:  2011-09-15       Impact factor: 2.486

Review 8.  Room for improvement in conducting and reporting non-inferiority randomized controlled trials on drugs: a systematic review.

Authors:  Grace Wangge; Olaf H Klungel; Kit C B Roes; Anthonius de Boer; Arno W Hoes; Mirjam J Knol
Journal:  PLoS One       Date:  2010-10-27       Impact factor: 3.240

Review 9.  Anticoagulant therapy for patients with ischaemic stroke.

Authors:  Graeme J Hankey
Journal:  Nat Rev Neurol       Date:  2012-05-08       Impact factor: 42.937

10.  Effect of Internet-Based Guided Self-help vs Individual Face-to-Face Treatment on Full or Subsyndromal Binge Eating Disorder in Overweight or Obese Patients: The INTERBED Randomized Clinical Trial.

Authors:  Martina de Zwaan; Stephan Herpertz; Stephan Zipfel; Jennifer Svaldi; Hans-Christoph Friederich; Frauke Schmidt; Andreas Mayr; Tony Lam; Carmen Schade-Brittinger; Anja Hilbert
Journal:  JAMA Psychiatry       Date:  2017-10-01       Impact factor: 21.596

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.